Expertise in
1
conditions

Zhengsheng L. Zou

Beijing, CN 
Expertise in
1
conditions
Beijing, CN 
OverviewLocationsClinical Research

Overview

Zhengsheng Zou practices in Beijing, China. Zou is highly rated in 1 condition, according to our data. Their top areas of expertise are Cirrhosis, Hepatitis, Autoimmune Hepatitis, and Alcoholic Cirrhosis.

Their clinical research consists of co-authoring 49 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Beijing, China
Other Locations
Key Laboratory Of Environmental Pollution Monitoring And Disease Control, Guiyang, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury
The Efficacy and Safety of 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent Drug-Induced Liver Injury
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drug: Methylprednisolone
Study Phase: Phase 1/Phase 2
A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursodeoxycholic Acid in PBC Patients With an Incomplete Biochemical Response to UDCA
A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursodeoxycholic Acid in PBC Patients With an Incomplete Biochemical Response to UDCA
Enrollment Status: Withdrawn
Publish Date: September 17, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

49 Total Publications

Model Prediction of Infection Risk After Glucocorticoid Treatment for Severe Drug-Induced Liver Injury: Globulin is a Core Predictive Factor.
Model Prediction of Infection Risk After Glucocorticoid Treatment for Severe Drug-Induced Liver Injury: Globulin is a Core Predictive Factor.
Journal: Drug design, development and therapy
Published: May 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zou's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile